Jakafi is marketed by Incyte in the United States and by Novartis as Jakavi® (ruxolitinib) outside the United States
.... so both will be sweating bullets ... hehe
Sorry mate I am a little tired so post quality is slipping today.
MSB Trading 2020 - a new dawn, page-401
-
- There are more pages in this discussion • 12,670 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.16 |
Change
-0.003(0.21%) |
Mkt cap ! $1.358B | |||
| Open | High | Low | Value | Volume |
| $1.15 | $1.20 | $1.15 | $1.855M | 1.584M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 22 | 70620 | $1.16 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.17 | 26523 | 16 |
View Market Depth
| Last trade - 12.11pm 16/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |